Susan Molineaux - Jun 17, 2021 Form 3 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Director
Signature
By: /s/ Andrew Gengos, Attorney-in-Fact
Stock symbol
CYT
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
3
Date filed
6/17/2021, 09:32 PM
Previous filing
May 13, 2021
Next filing
Nov 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYT Stock Option (Right to Buy) Jun 17, 2021 Common Stock 44K $1.67 Direct F1
holding CYT Stock Option (Right to Buy) Jun 17, 2021 Common Stock 16.4K $7.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will become exercisable as to 1/36th of the underlying shares of common stock at the end of each successive one-month period following the vesting commencement date, December 9, 2020, until the option is fully vested on the third anniversary of the vesting commencement date, subject to the Reporting Person's continued service on the Issuer's board of directors through the applicable vesting date.
F2 The option will become exercisable as to 1/36th of the underlying shares of common stock at the end of each successive one-month period following the vesting commencement date, February 5, 2021, until the option is fully vested on the third anniversary of the vesting commencement date, subject to the Reporting Person's continued service on the Issuer's board of directors through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney